ROBERT MARTINEZ: Open Payments
NPI 1306806542 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 11 payments from 7 companies in 2025. Trend: 2023 $481 · 2024 $323 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $101 |
| Medtronic, Inc. | 1 | $70 |
| Dexcom, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: INTERSTIM, Dexcom G6 Transmitter, OTEZLA, MOUNJARO, Ozempic, Rybelsus, GVOKE HYPOPEN, NUZYRA.
Industry payments across TX — which companies pay providers there.
